PhD Position in rAAV Gene Therapy and Industrial Downstream Processing Ruprecht-Karls-Universität Heidelberg in Germany

Join the team at Ruprecht-Karls-Universität Heidelberg and Roche for a PhD position focused on the industrial downstream processing of Adeno-Associated Viral (rAAV) vectors, a cutting-edge area in gene therapy. This opportunity allows you to contribute directly to the next generation of gene therapy solutions, working on high-impact projects that bridge academia and industry.

As a PhD candidate, you will be immersed in a modern, fully-equipped laboratory environment, collaborating with a highly engaged team of scientists. The research will center on the development and optimization of purification processes for rAAV, a key technology in the delivery of gene therapies. You will benefit from close mentorship, a supportive team, and access to a broad scientific network, ensuring your research meets the highest standards and has real-world impact.

The position is ideal for candidates with a strong background in biology, biotechnology, or related fields, and offers the chance to develop advanced skills in bioprocessing and pharmaceutical sciences. While specific funding details are not provided, the role is based at Roche in Germany, in partnership with Ruprecht-Karls-Universität Heidelberg.

Applicants should be motivated, collaborative, and eager to advance the field of gene therapy. The application process is online via the Roche careers portal. This is a unique opportunity to launch your scientific career in a dynamic and innovative environment.